Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi’s Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya

dc.contributor.author	Busakhala Nafthali.
dc.contributor.author	Waako Paul
dc.contributor.author	Chite Asirwa Fredrick
dc.contributor.author	Robert Strother Matthew
dc.contributor.author	Kipyegon Keter Alfred
dc.contributor.author	Kimutai Kigen Gabriel
dc.contributor.author	Loehrer Patrick J.
dc.date.accessioned	2018-11-06T06:39:22Z
dc.date.available	2018-11-06T06:39:22Z
dc.date.issued	2018-09
dc.identifier.uri	https://doi.org/10.1200/JGO.17.00077
dc.identifier.uri	http://ir.mu.ac.ke:8080/xmlui/handle/123456789/2167
dc.language.iso	en	en_US
dc.publisher	American Society of Clinical Oncology	en_US
dc.subject	Gemcitabine	en_US
dc.subject	Bleomycin Plus Vincristine	en_US
dc.subject	Kaposi’s Sarcoma	en_US
dc.subject	Antiretroviral Therapy	en_US
dc.title	Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi’s Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya	en_US
dc.type	Article	en_US

Files in this item

Files	Size	Format	View
There are no files associated with this item.